Skip to content

Medical emergency? What to do

Sirna drug helps vision in blindness-risk patients

3-RXPublished May 4, 20052 min read

Key points

  • Sirna Therapeutics Inc. on Tuesday said its experimental drug to treat the leading cause of Blindness improved vision in almost half of patients in a small, early-stage trial, without causing any drug-related side effects.
  • Roberto Guerciolini, chief medical officer of the tiny San Francisco-based biotechnology company, said the phase I data involved 14 patients with the Blindness-causing "wet" form of age-related macular degeneration.
  • "It was very impressive that more than 45 percent of the patients showed improvement in their visual acuity," he said, although the trial was too small to show statistical significance.
  • The data were presented at the annual meeting of the Association for Research in Vision and Ophthalmology being held in Fort Lauderdale, Florida.

Sirna Therapeutics Inc. on Tuesday said its experimental drug to treat the leading cause of Blindness improved vision in almost half of patients in a small, early-stage trial, without causing any drug-related side effects.

The phase I trial results for the company's lead experimental drug, Sirna-027, are the first human clinical data ever presented for a medicine that employs a technology called RNA interference. Such drugs are designed to prevent disease-causing genes from making their designated proteins.

Dr. Roberto Guerciolini, chief medical officer of the tiny San Francisco-based biotechnology company, said the phase I data involved 14 patients with the Blindness-causing "wet" form of age-related macular degeneration.

All patients received a single intra-eye injection of the medicine and were followed for one to three months. None of them saw a decline in their vision during the study period or evidence of drug-related side effects, Guerciolini said in an interview.

"It was very impressive that more than 45 percent of the patients showed improvement in their visual acuity," he said, although the trial was too small to show statistical significance.

He said patients deemed to have had improvements in visual acuity were able to see an additional three lines of an eye-test chart following treatment - a standard criterion for patients with the eye problem.

The data were presented at the annual meeting of the Association for Research in Vision and Ophthalmology being held in Fort Lauderdale, Florida.

Guerciolini said three doses of Sirna-027 were tested in the study - 100 micrograms, 200 micrograms and 400 micrograms - and that patients given injections of the highest doses showed the best results.

"Because we did not see a single adverse event in the trial, we are confident enough in our drug's safety to use higher doses and repeated doses of it in future trials," Guerciolini said. "And we are hoping they will prove able to benefit a majority of patients."

Based on the favorable safety and effectiveness data, Guerciolini said the company plans to begin a larger phase II trial using stronger doses of the medicine as soon as November, about three months sooner than Sirna's earlier plans.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.